Atlas Trials

Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies

Clinical trial NCT05419180 · COMPLETED

Trial details

NCT number
NCT05419180
Sponsor
Biocodex
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pharmacoresistant Focal Epilepsies
Start date
2022-10-13
Primary completion
2024-06-13
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.